Literature DB >> 30471261

Effect of contraceptive choice on rapid repeat pregnancy.

Maryl G Sackeim1, Elizabeth P Gurney2, Nathanael Koelper3, Mary D Sammel4, Courtney A Schreiber5.   

Abstract

OBJECTIVE: To describe the prevalence of rapid repeat pregnancy (RRP), defined as repeat pregnancy within 18 months of delivery, in a large health system and to determine the impact of contraceptive method on RRP. STUDY
DESIGN: Retrospective cohort.
RESULTS: The prevalence of RRP among patients who delivered in August 2014 (n=804) was 27.2%. After controlling for age and sociodemographic characteristics, women experiencing RRP were less likely to have used long-acting reversible contraception (LARC) [adjusted odds ratio (aOR) 0.45, 95% confidence interval (CI) 0.24-0.85, p=.014; RRP in 19% of implant and 18% of IUD users)] and more likely to have been prescribed a progestin-only pill (aOR 5.106, 95% CI 2.157-12.083, p<.001; RRP in 53% of users) compared to women choosing all other reversible contraceptive methods.
CONCLUSIONS: Postpartum LARC decreases the odds of RRP, while a prescription for progestin-only pills is not protective.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Long-acting reversible contraception; Postpartum LARC; Postpartum contraception; Rapid repeat pregnancy; Unintended pregnancy

Mesh:

Substances:

Year:  2018        PMID: 30471261     DOI: 10.1016/j.contraception.2018.11.008

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  2 in total

1.  Progestin-only pill use over 6 months postpartum.

Authors:  Suji Uhm; Nuria Garcia-Ruiz; Mitchell D Creinin; Aubrey Blanton; Melissa J Chen
Journal:  Contraception       Date:  2020-06-13       Impact factor: 3.375

Review 2.  Immediate Postpartum Long-Acting Reversible Contraception: Review of Insertion and Device Reimbursement Policies.

Authors:  Charlan D Kroelinger; Ekwutosi M Okoroh; Keriann Uesugi; Lisa Romero; Olivia R Sappenfield; Julia F Howland; Shanna Cox
Journal:  Womens Health Issues       Date:  2021-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.